- Home
- / Applied Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Applied Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$8.8
2024-10-29
Market Capitalization
$1 B
2024-10-29
Revenue
$455 K
FY, 2024
CreditSafe Score
?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 10.0M | 455.0K | ||||||
| General and administrative expense | 582.0K | 2.0M | 13.2M | 32.7M | 43.0M | 27.3M | 20.6M | 56.0M |
| Operating expense total | 4.3M | 13.5M | 45.6M | 94.5M | 83.0M | 104.8M | ||
| EBIT | (4.3M) | (13.5M) | (45.6M) | (94.5M) | (105.6M) | (82.9M) | (64.5M) | (104.3M) |
| EBIT margin, % | -22922.9% | |||||||
| Interest expense | 93.0K | 559.0K | 555.0K | 685.0K | 1.4M | 3.5M | ||
| Net Income | (4.3M) | (16.5M) | (45.5M) | (94.0M) | (105.6M) | (82.5M) | (119.8M) | (105.6M) |
| EPS | (2.2) | (1.0) | (0.8) |